Tumors of low malignant potential

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Tumor Biology

Background:

• Increasing interest in defining tumors of low malignant potential over the past two decades.
• Focus on diagnosis, treatment, and biologic behavior of these tumors.

Purpose of the Study:

• To review prognostic factors and treatment strategies for tumors of low malignant potential.
• To clarify the role of surgery, chemotherapy, and second-look laparotomy.

Main Methods:

• Review of prognostic factors including stage, cellular DNA content, and residual disease.
• Evaluation of surgical staging and cytoreductive surgery.
• Assessment of adjuvant chemotherapy efficacy and role of second-look laparotomy.

Main Results:

• Stage, cellular DNA content, and residual disease are significant prognostic factors.
• Surgical staging and optimal cytoreductive surgery are recommended.
• Adjuvant chemotherapy is generally not efficacious, but may benefit a subset of patients.
• Second-look laparotomy is not indicated outside of research settings.

Conclusions:

• Optimal surgical management is crucial for tumors of low malignant potential.
• Chemotherapy should be considered selectively based on prognostic factors.
• Current evidence does not support routine second-look laparotomy.